Raymond James Trust N.A. Biomarin Pharmaceutical Inc Transaction History

Raymond James Trust N.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $238,290 - $297,349	-3,208 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$71.72 - $91.47 $32,202 - $41,070	-449 Reduced 12.28%	3,208 $283,000
Q3 2021 Oct 18, 2021	BUY	$74.77 - $85.47 $17,645 - $20,170	236 Added 6.9%	3,657 $283,000
Q2 2021 Jul 20, 2021	SELL	$75.51 - $84.79 $226 - $254	-3 Reduced 0.09%	3,421 $285,000
Q1 2021 May 03, 2021	SELL	$74.73 - $90.69 $33,030 - $40,084	-442 Reduced 11.43%	3,424 $259,000
Q4 2020 Jan 13, 2021	BUY	$72.61 - $90.2 $32,311 - $40,139	445 Added 13.01%	3,866 $339,000
Q3 2020 Oct 14, 2020	SELL	$71.87 - $131.03 $6,324 - $11,530	-88 Reduced 2.51%	3,421 $260,000
Q2 2020 Jul 16, 2020	BUY	$79.55 - $124.22 $18,455 - $28,819	232 Added 7.08%	3,509 $433,000
Q1 2020 Apr 17, 2020	BUY	$71.37 - $96.85 $233,879 - $317,377	3,277 New	3,277 $277,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.